medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2016, Número 618

<< Anterior Siguiente >>

Rev Med Cos Cen 2016; 73 (618)


Degeneración macular relacionada con la edad

Maroto JP

Idioma: Español
Referencias bibliográficas: 14
Paginas: 49-51
Archivo PDF: 154.07 Kb.


RESUMEN

La degeneración macular relacionada con la edad es una enfermedad de alta prevalencia con secuelas limitantes para la calidad de vida de una población mundial que está envejeciendo. Dentro de las estrategias de prevención está todo lo relacionado a un estilo de vida saludable de manera que se tenga un envejecimiento ocular libre de enfermedad retiniana.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Age-Related Eye Disease Study Research Group. (2001). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Archives of Ophthalmology (Chicago, Ill.: 1960), 119(10), 1417- 1436.

  2. Ambati, J., Atkinson, J. P., & Gelfand, B. D. (2013). Immunology of age-related macular degeneration. Nature Reviews. Immunology, 13(6), 438-451.

  3. Ardeljan, D., & Chan, C.-C. (2013). Aging is not a disease: distinguishing age-related macular degeneration from aging. Progress in Retinal and Eye Research, 37, 68-89.

  4. Chew, E. Y., Clemons, T., SanGiovanni, J. P., Danis, R., Domalpally, A., McBee, W., … Ferris, F. L. with AREDS2 Research Group. (2012). The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). Ophthalmology, 119(11), 2282- 2289.

  5. Hanout, M., Ferraz, D., Ansari, M., Maqsood, N., Kherani, S., Sepah, Y. J., … Nguyen, Q. D. (2013). Therapies for neovascular agerelated macular degeneration: current approaches and pharmacologic agents in development. BioMed Research International, 2013, 830837.

  6. Holz, F. G., Schmitz-Valckenberg, S., & Fleckenstein, M. (2014). Recent developments in the treatment of age-related macular degeneration. The Journal of Clinical Investigation, 124(4), 1430-1438.

  7. Jarrett, S. G., & Boulton, M. E. (2012). Consequences of oxidative stress in age-related macular degeneration. Molecular Aspects of Medicine, 33(4), 399-417.

  8. Kanagasingam, Y., Bhuiyan, A., Abràmoff, M. D., Smith, R. T., Goldschmidt, L., & Wong, T. Y. (2014). Progress on retinal image analysis for age related macular degeneration. Progress in Retinal and Eye Research, 38, 20-42.

  9. Parmeggiani, F., Sorrentino, F. S., Romano, M. R., Costagliola, C., Semeraro, F., Incorvaia, C., … Rubini, M. (2013). Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks. Mediators of Inflammation, 2013, 435607.

  10. Ratnapriya, R., & Chew, E. Y. (2013). Age-related macular degenerationclinical review and genetics update. Clinical Genetics, 84(2), 160-166.

  11. Rhoades, W., Dickson, D., & Do, D. V. (2015). Potential role of lampalizumab for treatment of geographic atrophy. Clinical Ophthalmology (Auckland, N.Z.), 9, 1049-1056.

  12. Schleicher, M., Weikel, K., Garber, C., & Taylor, A. (2013). Diminishing risk for age-related macular degeneration with nutrition: a current view. Nutrients, 5(7), 2405-2456.

  13. Tokarz, P., Kaarniranta, K., & Blasiak, J. (2013). Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD). Biogerontology, 14(5), 461- 482.

  14. Tranos, P., Vacalis, A., Asteriadis, S., Koukoula, S., Vachtsevanos, A., Perganta, G., & Georgalas, I. (2013). Resistance to antivascular endothelial growth factor treatment in age-related macular degeneration. Drug Design, Development and Therapy, 7, 485-490.




2020     |     www.medigraphic.com